{"id":"juvista-avotermin","safety":{"commonSideEffects":[{"rate":null,"effect":"Erythema at injection site"},{"rate":null,"effect":"Edema"},{"rate":null,"effect":"Pruritus"},{"rate":null,"effect":"Local irritation"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Avotermin works by enhancing the inflammatory phase of wound healing and promoting a fetal-like healing response that minimizes collagen deposition and scar formation. By exogenously delivering TGF-β3 at the wound site, it shifts the healing process toward regeneration rather than fibrosis, resulting in improved cosmetic outcomes and reduced scar visibility.","oneSentence":"Avotermin is a recombinant human transforming growth factor beta-3 (TGF-β3) that modulates wound healing to reduce scarring.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:49:04.022Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Reduction of scar formation in acute surgical wounds"},{"name":"Improvement of cosmetic outcomes in wound healing"}]},"trialDetails":[{"nctId":"NCT00742443","phase":"PHASE3","title":"Juvista in Scar Revision Surgery of Disfiguring Scars","status":"COMPLETED","sponsor":"Renovo","startDate":"2008-12","conditions":"Cicatrix","enrollment":350},{"nctId":"NCT01029158","phase":"PHASE1","title":"A Trial to Compare the Efficacy of Two Formulations of Avotermin Against Placebo","status":"COMPLETED","sponsor":"Renovo","startDate":"2009-08","conditions":"Scar Improvement","enrollment":84},{"nctId":"NCT00836147","phase":"PHASE1, PHASE2","title":"Exploratory Study of the Efficacy and Safety of Juvista 250ng When Administered Following Excision of Ear Lobe Keloids","status":"COMPLETED","sponsor":"Renovo","startDate":"2009-02","conditions":"Keloid","enrollment":20},{"nctId":"NCT00430326","phase":"PHASE2","title":"Juvista (Avotermin) in Scars Following Varicose Vein Removal","status":"COMPLETED","sponsor":"Renovo","startDate":"2006-11","conditions":"Varicose Veins, Cicatrix","enrollment":156},{"nctId":"NCT00710333","phase":"PHASE1, PHASE2","title":"Safety of Juvista When Administered Following Excision of Ear Lobe Keloids","status":"COMPLETED","sponsor":"Renovo","startDate":"2008-07","conditions":"Keloid","enrollment":10},{"nctId":"NCT00821457","phase":"NA","title":"Juvista in the Non-surgical Improvement of Existing Scars","status":"WITHDRAWN","sponsor":"Renovo","startDate":"2009-01","conditions":"Scars","enrollment":40},{"nctId":"NCT00984581","phase":"PHASE1, PHASE2","title":"Safety and Efficacy Study of Avotermin (Juvista) in Female Subjects","status":"COMPLETED","sponsor":"Renovo","startDate":"2003-04","conditions":"Cicatrix, Wound Healing","enrollment":35},{"nctId":"NCT00984503","phase":"PHASE2","title":"Investigation of the Accelerated Healing and Anti-scarring Potential of Avotermin (Juvista) in Split Skin Graft Donor Sites","status":"COMPLETED","sponsor":"Renovo","startDate":"2003-10","conditions":"Cicatrix, Wound Healing","enrollment":102},{"nctId":"NCT00978302","phase":"PHASE1","title":"Safety Study of Repeated, Escalating Doses of Intradermal Avotermin (Juvista)","status":"COMPLETED","sponsor":"Renovo","startDate":"2001-05","conditions":"Cicatrix, Wound Healing","enrollment":55},{"nctId":"NCT00978367","phase":"PHASE1, PHASE2","title":"Investigation of the Safety, Dosing Frequency and Anti-Scarring Potential of Two Concentrations of Intradermal Avotermin (Juvista)","status":"COMPLETED","sponsor":"Renovo","startDate":"2002-02","conditions":"Cicatrix, Wound Healing, Re-epithelialization","enrollment":43},{"nctId":"NCT00469235","phase":"PHASE1, PHASE2","title":"Trial of Juvista (Avotermin) Following Removal of Ear Lobe Keloid Scars","status":"COMPLETED","sponsor":"Renovo","startDate":"2007-06","conditions":"Keloid","enrollment":20},{"nctId":"NCT00977951","phase":"PHASE1, PHASE2","title":"Genomic Changes Associated With the Use of Intradermal Avotermin (Juvista) in Small Wounds in Healthy Male Subjects","status":"COMPLETED","sponsor":"Renovo","startDate":"2002-09","conditions":"Cicatrix, Wound Healing","enrollment":20},{"nctId":"NCT00847795","phase":"PHASE1, PHASE2","title":"Efficacy and Safety of Intradermal RN1001 (Avotermin) in Elderly Subjects.","status":"COMPLETED","sponsor":"Renovo","startDate":"2002-09","conditions":"Cicatrix","enrollment":42},{"nctId":"NCT00432211","phase":"PHASE2","title":"Juvista (Avotermin) in the Prevention or Improvement of Scar Appearance Following Scar Revision Surgery.","status":"UNKNOWN","sponsor":"Renovo","startDate":"2006-05","conditions":"Cicatrix","enrollment":60},{"nctId":"NCT00432328","phase":"PHASE2","title":"Juvista (Avotermin) in Breast Reduction Surgery Scars","status":"TERMINATED","sponsor":"Renovo","startDate":"2006-10","conditions":"Mammaplasty, Cicatrix","enrollment":39},{"nctId":"NCT00629811","phase":"PHASE2","title":"Improvement in Scar Appearance Following Injection of Avotermin (Juvista) Into Skin Incisions Made in Healthy Men and Women","status":"COMPLETED","sponsor":"Renovo","startDate":"2006-09","conditions":"Cicatrix","enrollment":78},{"nctId":"NCT00627536","phase":"PHASE2","title":"Scar-Improvement Efficacy and Safety of a Single Intradermal Injection of Avotermin (Juvista) Administered Following Full-Thickness Skin Incisions","status":"COMPLETED","sponsor":"Renovo","startDate":"2006-07","conditions":"Cicatrix","enrollment":39},{"nctId":"NCT00594581","phase":"PHASE2","title":"Anti-Scarring Efficacy and Safety of Intradermal Juvista (Avotermin) in Healthy Males","status":"COMPLETED","sponsor":"Renovo","startDate":"2003-10","conditions":"Cicatrix","enrollment":71}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["juvista","RN1001","Juvista","RN1001, TGFβ3"],"phase":"phase_3","status":"active","brandName":"Juvista (Avotermin)","genericName":"Juvista (Avotermin)","companyName":"Renovo","companyId":"renovo","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Avotermin is a recombinant human transforming growth factor beta-3 (TGF-β3) that modulates wound healing to reduce scarring. Used for Reduction of scar formation in acute surgical wounds, Improvement of cosmetic outcomes in wound healing.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}